

Founded in 2020, Prodancy operates in the Health Tech sector, offering innovative and affordable surgical consumables for joint replacement surgeries. The company has launched the Vizbl Surgical helme...
Funding stage:
Undisclosed
Last funding:
26/11/2024
Total funding:
$254.02K+
Revenue:
Investors
Employee count:
27
Last 90d
27
Last 90d
Web traffic:
55
55
Last 30d
Last 30d
Prodancy: Cap Table Highlights
A snapshot of cap table and shareholder metrics
- Total Shareholders51
- Latest Filing Date06 Jan 2025
- Funding Events13
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Prodancy
As of 07 January 2025, Prodancy's equity is held by 49 shareholders, with the top three being Pradeep Vamana, Venkatesh Parthasarathy, and Centre For Cellular and Molecular Platforms ( C - CAMP).
Pradeep Vamana holds the largest stake in Prodancy at 37.4% as of 07 January 2025.
As of 07 January 2025, founders collectively hold 74.9% equity in Prodancy.
As of 07 January 2025, investors collectively hold 16.9% equity in Prodancy.
Prodancy's ESOP pool stands at 6.2% of total equity as of 07 January 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links